Transfer of sodium iodide symporter gene into glioma cells by recombinant adenovirus and radioiodine therapy for the glioma cells in vitro and in nude mice.
- Author:
Wei LI
1
;
Jian TAN
;
Wei ZHENG
;
Ning LI
Author Information
- Publication Type:Journal Article
- MeSH: Adenoviridae; genetics; Animals; Brain Neoplasms; pathology; therapy; Genetic Therapy; Glioma; pathology; therapy; Humans; In Vitro Techniques; Iodides; Iodine Radioisotopes; metabolism; therapeutic use; Mice, Nude; Symporters; genetics; Transfection
- From: Chinese Journal of Oncology 2011;33(2):101-104
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the possibility of tranfecting hNIS and hTPO genes into gliomas cells by recombinant adenovirus for radioactive iodide treatment.
METHODSTo tranfect hNIS gene into human glioma cell line U251 by recombinant adenovirus. The biological functions of the cells stably expressing hNIS and hTPO genes were assessed by (125)I uptake assay, (125)I influx-course and (125)I-efflux-course. A glioma model was established with inoculation of the U251 cells in nude mice, and the inhibiting effect of (131)I on the tumor growth was tested in the mouse models.
RESULTSThe hNIS and hTPO genes were successfully transfected into human gliomas cell line U251 cells by recombinant adenovirus. The radioactive iodide could be intaken by the tumor cells mediated by hNIS gene. The uptake of (125)I was higher in cell lines hNIS-U251 and hNIS-hTPO-U251 cells than in cell line U251 cells. The tumor volume of the mice after (131)I treatment was significantly decreased in comparison with that before treatment.
CONCLUSIONRadioactive (131)I treatment after HNIS-based gene transfer can be enhanced and effectively inhibit the tumor growth in nude mice.
